LifeMD, Inc.
LFMD
$4.27
-$0.40-8.57%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 42.16% | 38.63% | 32.85% | 28.15% | 14.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.16% | 38.63% | 32.85% | 28.15% | 14.77% |
| Cost of Revenue | 13.52% | 12.62% | 9.36% | 1.25% | -12.67% |
| Gross Profit | 46.42% | 42.73% | 36.78% | 33.16% | 20.41% |
| SG&A Expenses | 38.75% | 33.06% | 19.33% | 4.45% | -6.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 33.55% | 19.60% | -5.68% | -15.10% | -22.71% |
| Total Operating Expenses | 37.04% | 31.64% | 18.89% | 5.24% | -5.97% |
| Operating Income | -0.83% | 10.30% | 39.50% | 63.49% | 58.76% |
| Income Before Tax | 16.67% | 22.28% | 40.80% | 61.01% | 49.79% |
| Income Tax Expenses | 83.12% | 18.66% | 18.66% | 18.66% | 4,584.42% |
| Earnings from Continuing Operations | 15.30% | 21.76% | 40.19% | 60.38% | 49.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 87.65% | 18.60% | -118.81% | -435.76% | -905.90% |
| Net Income | 21.85% | 21.56% | 35.56% | 54.77% | 44.31% |
| EBIT | -0.83% | 10.30% | 39.50% | 63.49% | 58.76% |
| EBITDA | 0.10% | 2.50% | 37.23% | 63.84% | 59.05% |
| EPS Basic | 35.03% | 33.09% | 41.00% | 55.11% | 44.75% |
| Normalized Basic EPS | 31.52% | 24.96% | 34.28% | 52.60% | 47.85% |
| EPS Diluted | 34.25% | 32.36% | 40.87% | 55.09% | 44.94% |
| Normalized Diluted EPS | 31.52% | 24.96% | 34.28% | 52.60% | 47.85% |
| Average Basic Shares Outstanding | 22.42% | 19.88% | 14.56% | 9.23% | 5.65% |
| Average Diluted Shares Outstanding | 22.42% | 19.88% | 14.56% | 9.23% | 5.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.28% | -0.27% | -0.55% | -1.21% | -0.74% |
